Get the Stockscreener App
1.31
0.77%
0.01
Neuronetics Inc stock is traded at $1.31, with a volume of 1.35M.
It is up +0.77% in the last 24 hours and down -54.51% over the past month.
Neuronetics Inc a commercial stage medical technology company focused on designing, developing and marketing products that improve the quality of life for patients who suffer from psychiatric disorders. Its first commercial product, the NeuroStar Advanced Therapy System, is a non-invasive and non-systemic office-based treatment that uses transcranial magnetic stimulations, or TMS, to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company designed the NeuroStar Advanced Therapy as a non-invasive therapeutic alternative to treat patients who suffer from MDD and to address many of the key limitations of existing treatment options.
See More
Previous Close:
$1.30
Open:
$1.29
24h Volume:
1.35M
Relative Volume:
0.81
Market Cap:
$89.72M
Revenue:
$69.23M
Net Income/Loss:
$-33.10M
P/E Ratio:
-1.1102
EPS:
-1.18
Net Cash Flow:
$-39.26M
1W Performance:
-34.17%
1M Performance:
-54.51%
6M Performance:
-67.33%
1Y Performance:
+56.81%
1-Day Range:
$1.25
$1.36
1-Week Range:
$1.25
$2.03
52-Week Range:
$0.84
$5.92
Neuronetics Inc Stock (STIM) Company Profile
Name
Neuronetics Inc
Sector
Industry
Phone
877-600-7555
Address
3222 PHOENIXVILLE PIKE, MALVERN, PA
Compare STIM with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
STIM
Neuronetics Inc
|
1.31 | 89.03M | 69.23M | -33.10M | -39.26M | -1.18 |
|
ABT
Abbott Laboratories
|
128.11 | 215.57B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
BSX
Boston Scientific Corp
|
96.88 | 143.20B | 19.35B | 2.78B | 3.82B | 1.8696 |
|
SYK
Stryker Corp
|
368.27 | 137.86B | 24.38B | 2.94B | 4.07B | 7.6159 |
|
MDT
Medtronic Plc
|
101.20 | 127.43B | 34.76B | 4.79B | 5.21B | 3.7049 |
|
EW
Edwards Lifesciences Corp
|
85.13 | 48.80B | 5.88B | 1.34B | 799.60M | 2.3489 |
Neuronetics Inc Stock (STIM) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-13-24 | Downgrade | William Blair | Outperform → Mkt Perform |
| Oct-13-21 | Downgrade | BTIG Research | Buy → Neutral |
| Oct-13-21 | Downgrade | William Blair | Outperform → Mkt Perform |
| Jan-22-21 | Upgrade | William Blair | Mkt Perform → Outperform |
| Feb-06-20 | Initiated | BTIG Research | Buy |
| Jul-24-18 | Initiated | Canaccord Genuity | Buy |
View All
Neuronetics Inc Stock (STIM) Latest News
Neuronetics, Inc.'s (NASDAQ:STIM) 36% Loss Last Week Hit Both Individual Investors Who Own 32% as Well as Institutions - 富途牛牛
Is Neuronetics Inc. (NRC) stock suitable for passive index fundsPortfolio Risk Report & AI Driven Price Forecasts - newser.com
TRICARE Expands TMS Coverage for Teens as Neuronetics Gains Major Policy Win - MyChesCo
Neuronetics to Participate at the Piper Sandler 37th Annual Healthcare Conference - Yahoo Finance
Will Neuronetics Inc. (NRC) stock profit from fiscal stimulus - newser.com
What does recent volatility data suggest for Neuronetics Inc.2025 Volume Leaders & Technical Confirmation Trade Alerts - newser.com
How Neuronetics Inc. (NRC) stock moves in volatile trading sessionsJuly 2025 Trends & AI Driven Price Forecasts - newser.com
Is Neuronetics Inc. (NRC) stock a buy before new product rollout2025 Top Decliners & Reliable Entry Point Alerts - newser.com
Tools to monitor Neuronetics Inc. recovery probabilityWeekly Investment Recap & Fast Moving Market Watchlists - newser.com
Detecting support and resistance levels for Neuronetics Inc.Entry Point & Safe Capital Investment Plans - newser.com
Why Neuronetics Inc. stock remains on watchlists2025 Dividend Review & Scalable Portfolio Growth Ideas - newser.com
Can trapped investors hope for a rebound in Neuronetics Inc.Quarterly Market Summary & High Return Stock Watch Alerts - newser.com
Using AI based signals to follow Neuronetics Inc.Quarterly Trade Summary & Real-Time Volume Surge Alerts - newser.com
Top 3 Health Care Stocks Which Could Rescue Your Portfolio In November - inkl
Mile Marker Honored in 2025 Healthcare Marketing Impact Awards - MarTech Cube
Is Neuronetics Inc. stock attractive for long term wealth buildingJuly 2025 Final Week & Reliable Volume Spike Trade Alerts - newser.com
Will Neuronetics Inc. stock maintain growth storyMarket Activity Report & Reliable Entry Point Trade Alerts - newser.com
Will Neuronetics Inc. bounce back from current supportProfit Target & Consistent Profit Alerts - newser.com
Will Neuronetics Inc. stock maintain dividend yieldEarnings Recap Report & Advanced Swing Trade Entry Alerts - newser.com
Is Neuronetics Inc. stock a top momentum playWeekly Risk Report & Free Real-Time Volume Trigger Notifications - newser.com
Will Neuronetics Inc. continue its uptrendStop Loss & Daily Stock Momentum Reports - newser.com
Sentiment analysis tools applied to Neuronetics Inc.Portfolio Value Summary & Weekly Consistent Profit Watchlists - newser.com
Neuronetics Inc. R (NRC.F) Q1 FY2025 earnings call transcript - Yahoo Finance
Neuronetics Sees Strong Growth and Leadership Shift as Integration Gains Momentum - MSN
How Neuronetics Inc. stock reacts to job market dataMarket Activity Report & Verified Chart Pattern Signals - Fundação Cultural do Pará
Slammed 29% Neuronetics, Inc. (NASDAQ:STIM) Screens Well Here But There Might Be A Catch - simplywall.st
Neuronetics Inc Stock (STIM) Financials Data
Revenue
Net Income
Cash Flow
EPS
5.84%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):